We still need: Larger, long-term studies specifically focusing on psoriasis and PsA patients More data on optimal dosing and treatment duration Better understanding of how these drugs interact with current psoriasis and PsA treatments Empowering Your Psoriasis and PsA Management: Explore GLP-1 Options If you have psoriasis or PsA and struggle with weight management or treatment resistance, GLP-1 receptor agonists offer a new avenue for improving your condition
Those who want to reduce skin aging
3 If you are a Medicare member, ask your provider about GLP-1 Bridge eligibility Starting July 1, 2026, the Medicare GLP-1 Bridge provides weight-loss access to Wegovy at $50 per month through December 31, 2027, outside the Part D benefit
Maximum results are seen at 1220 weeks of consistent daily use
Carcinogenesis 81 SekharK
NAC When it comes to producing glutathione, NAC (N-acetyl l-cysteine) is an amazing supplement that you can get your hands on